Association of cardiometabolic risks with body composition in hemodialysis patients

N Arslan1

  • 1Nutrition and Dietetic Department, Ataturk Faculty of Health Sciences, Dicle University, Diyarbakır, Turkey. nuracar_1986@hotmail.com.

Insights

Body fat indices, not just BMI, significantly elevate cardiovascular disease risk in hemodialysis patients. Evaluating body fat ratios is crucial for managing cardiometabolic risks in this population.

Area of Science:

  • Nephrology
  • Cardiology
  • Metabolic Health

Background:

  • High body fat percentage is a known risk factor for cardiovascular disease.
  • Hemodialysis (HD) patients with chronic kidney disease (CKD) are at increased risk for cardiovascular complications.
  • Understanding body composition's role in cardiometabolic risk is vital for this patient group.

Purpose of the Study:

  • To investigate the relationship between body composition and cardiometabolic risks in hemodialysis patients.
  • To determine if body fat indices independently predict cardiometabolic risk beyond Body Mass Index (BMI).

Main Methods:

  • Study included CKD patients undergoing HD between March 2020 and September 2021.
  • Body composition was analyzed using bioelectrical impedance analysis (BIA).
  • Cardiometabolic risk was assessed using Framingham risk scores and various body composition indices (LTI/FTI, BSI, VAI).

Main Results:

  • 15.96% of HD patients exhibited high cardiometabolic risk based on Framingham scores.
  • Higher visceral adiposity index (VAI) was significantly associated with increased Framingham risk scores (p=0.002).
  • Adipose tissue indices, including VAI, predicted increased Framingham risk scores independently of BMI.

Conclusions:

  • Adipose tissue indices are significant predictors of cardiometabolic risk in hemodialysis patients.
  • Evaluating body fat ratios is recommended for assessing cardiovascular disease risk in HD patients.
  • These findings suggest a need to incorporate body composition analysis into routine cardiovascular risk assessment for HD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
50
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
45
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
60
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
33
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
52